Zhuang Y - Search Results

1

Inhibiting ferroptosis: A novel approach for stroke therapeutics.

Jin Y, Zhuang Y, Liu M, Che J, Dong X. Jin Y, et al. Among authors: zhuang y. Drug Discov Today. 2021 Apr;26(4):916-930. doi: 10.1016/j.drudis.2020.12.020. Epub 2021 Jan 4. Drug Discov Today. 2021. PMID: 33412287 Review.

2

GSH Activated Biotin-tagged Near-Infrared Probe for Efficient Cancer Imaging.

Guo R, Huang F, Zhang B, Yan Y, Che J, Jin Y, Zhuang Y, Dong R, Li Y, Tan B, Song R, Hu Y, Dong X, Li X, Lin N. Guo R, et al. Among authors: zhuang y. Theranostics. 2019 May 26;9(12):3515-3525. doi: 10.7150/thno.32742. eCollection 2019. Theranostics. 2019. PMID: 31281494 Free PMC article.

3

Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy.

Jin Y, Zhuang Y, Dong X, Liu M. Jin Y, et al. Among authors: zhuang y. Expert Rev Anticancer Ther. 2021 Aug;21(8):841-851. doi: 10.1080/14737140.2021.1915136. Epub 2021 Apr 15. Expert Rev Anticancer Ther. 2021. PMID: 33831324 Review.

4

Bruton's tyrosine kinase inhibitors in primary central nervous system lymphoma-evaluation of anti-tumor efficacy and brain distribution.

Yu H, Kong H, Li C, Dong X, Wu Y, Zhuang Y, Han S, Lei T, Yang H. Yu H, et al. Among authors: zhuang y. Transl Cancer Res. 2021 May;10(5):1975-1983. doi: 10.21037/tcr-21-50. Transl Cancer Res. 2021. PMID: 35116520 Free PMC article.

5

Altered pathways and targeted therapy in double hit lymphoma.

Zhuang Y, Che J, Wu M, Guo Y, Xu Y, Dong X, Yang H. Zhuang Y, et al. J Hematol Oncol. 2022 Mar 18;15(1):26. doi: 10.1186/s13045-022-01249-9. J Hematol Oncol. 2022. PMID: 35303910 Free PMC article. Review.

6

Peripheral immune cell profiling of double-hit lymphoma by mass cytometry.

Lei T, Wu G, Xu Y, Zhuang W, Lu J, Han S, Zhuang Y, Dong X, Yang H. Lei T, et al. Among authors: zhuang w, zhuang y. BMC Cancer. 2023 Feb 23;23(1):184. doi: 10.1186/s12885-023-10657-0. BMC Cancer. 2023. PMID: 36823603 Free PMC article.

7

Discovery of orally bioavailable phenyltetrazolium derivatives for the acute treatment and the secondary prevention of ischemic stroke.

Lu Y, Lin H, Xu Y, Shen Z, Guo Y, Jin Y, Shi Q, Chen H, Zhuang Y, Huang W, Che J, Dai H, Dong X. Lu Y, et al. Among authors: zhuang y. Eur J Med Chem. 2024 Sep 5;275:116542. doi: 10.1016/j.ejmech.2024.116542. Epub 2024 Jun 1. Eur J Med Chem. 2024. PMID: 38875807

8

Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical Scavengers.

Lu Y, Shen Z, Xu Y, Lin H, Shen L, Jin Y, Guo Y, Lu J, Li L, Zhuang Y, Jin Y, Zhuang W, Huang W, Dong X, Dai H, Che J. Lu Y, et al. Among authors: zhuang w, zhuang y. J Med Chem. 2024 Jul 25;67(14):11712-11731. doi: 10.1021/acs.jmedchem.4c00211. Epub 2024 Jul 12. J Med Chem. 2024. PMID: 38996382

9

Nutritional health aspects and functional properties of nut yogurt: Future perspectives.

Zhai J, Zhuang Y, Sun L, Gu Y, Fan X. Zhai J, et al. Among authors: zhuang y. Food Chem X. 2024 Dec 20;25:102102. doi: 10.1016/j.fochx.2024.102102. eCollection 2025 Jan. Food Chem X. 2024. PMID: 39810957 Free PMC article. Review.

10

Corrigendum to "Comparative study of transcriptomic alterations in sepsis-induced acute liver injury: Deciphering the role of alternative splicing in mouse models" [Int. Immunopharmacol. 146 (2025) 113878].

Nie K, Kadier A, Jia S, Liu D, Tong N, Tuerxun M, Aisha A, Peng H, Zhuang Y, Chen Y, Jiang J, Sun M, Fang Y, Chen H. Nie K, et al. Among authors: zhuang y. Int Immunopharmacol. 2025 Jan 13:114077. doi: 10.1016/j.intimp.2025.114077. Online ahead of print. Int Immunopharmacol. 2025. PMID: 39809677 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,256 results

Search Page

Filters